These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 11507078

  • 1. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW.
    Cancer Res; 2001 Aug 15; 61(16):6239-47. PubMed ID: 11507078
    [Abstract] [Full Text] [Related]

  • 2. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM.
    Oncogene; 2002 Nov 07; 21(51):7883-90. PubMed ID: 12420225
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG.
    Oncogene; 2000 Sep 21; 19(40):4660-7. PubMed ID: 11030155
    [Abstract] [Full Text] [Related]

  • 5. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 6. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW.
    J Cell Physiol; 2003 Jan 15; 194(1):88-99. PubMed ID: 12447993
    [Abstract] [Full Text] [Related]

  • 7. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type RII receptor.
    Freeman JW, Mattingly CA, Strodel WE.
    J Cell Physiol; 1995 Oct 15; 165(1):155-63. PubMed ID: 7559796
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower WR, Salhab KF, McGrath P, Strodel W, Freeman JW.
    Anticancer Res; 2000 Oct 15; 20(1A):43-51. PubMed ID: 10769633
    [Abstract] [Full Text] [Related]

  • 9. Restoration of expression of transforming growth factor-beta type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2'-deoxycytidine.
    Zhang Q, Rubenstein JN, Liu VC, Park I, Jang T, Lee C.
    Life Sci; 2005 Jan 21; 76(10):1159-66. PubMed ID: 15620579
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ.
    Nat Genet; 1999 Oct 21; 23(2):222-7. PubMed ID: 10508522
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
    Heegaard AM, Xie Z, Young MF, Nielsen KL.
    J Cell Biochem; 2004 Oct 15; 93(3):463-75. PubMed ID: 15372625
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer.
    Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, Lee HS, Kim NK, Kim SJ.
    Oncogene; 1999 Dec 02; 18(51):7280-6. PubMed ID: 10602482
    [Abstract] [Full Text] [Related]

  • 16. Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells.
    Chang J, Lee C, Hahm KB, Yi Y, Choi SG, Kim SJ.
    Oncogene; 2000 Jan 06; 19(1):151-4. PubMed ID: 10644990
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
    Jennings R, Alsarraj M, Wright KL, Muñoz-Antonia T.
    Oncogene; 2001 Oct 18; 20(47):6899-909. PubMed ID: 11687969
    [Abstract] [Full Text] [Related]

  • 18. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
    Jiang W, Tillekeratne MP, Brattain MG, Banerji SS.
    Biochemistry; 1997 Dec 02; 36(48):14786-93. PubMed ID: 9402753
    [Abstract] [Full Text] [Related]

  • 19. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
    Jungert K, Buck A, von Wichert G, Adler G, König A, Buchholz M, Gress TM, Ellenrieder V.
    Cancer Res; 2007 Feb 15; 67(4):1563-70. PubMed ID: 17308095
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
    Park SH, Birchenall-Roberts MC, Yi Y, Lee BI, Lee DK, Bertolette DC, Fu T, Ruscetti F, Kim SJ.
    Cell Growth Differ; 2001 Jan 15; 12(1):9-18. PubMed ID: 11205746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.